Under what conditions is trichloroethylene likely to be a carcinogen in humans?

Human and Ecological Risk Assessment (HERA)

Volumn 7, Issue 4, 2001, Pages 687-716

  Clewell III, Harvey J ^a,e   Barton, Hugh A ^b   Maull, Elizabeth A ^c   Andersen, Melvin E ^d  

^a ICF Consulting   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c USAF   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e KS Crump Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23044530651     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Andersen ME, Meek B, Boorman GA, et al. 2000. Lessons learned applying the USEPA's proposed cancer guidelines to specific compounds. Toxicol Sci 53:159-72
2. Andersen ME, Mills JJ, Jirtle RL, et al. 1995. Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102:223-37
3. Anna CH, Maronpot RR, Pereira MA, et al. 1994. Ras proto-oncogene activation in dichloroacetic acid, trichloroethylene and tetrachloroethylene induced liver tumors in B6C3F1 mice. Carcinogenesis 15:2255-61
4. Antilla A, Pukkala E, Sallmen M, et al. 1995 Cancer incidence among Finnish workers exposed to halogenated hydrocarbons. J Occup Environ Med 37(7):797
5. Ashby J, Brady A, Elcombe CR, et al. 1994. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Human Exp Toxicol 13(suppl 2):S1-S117
6. Axelson O, Selden A, Andersson K, et al. 1994. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J Occup Med 36:556-62
7. Barton HA, Bull R, Schultz I, et al. 1999. Dichloroacetate (DCA) dosimetry: Interpreting DCA-induced liver cancer dose response and the potential for DCA to contribute to trichloroethylene-induced liver cancer. Toxicol Lett 106:9-21
8. Barton HA and Clewell HJ. 2000. Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment. Environ Health Perspect 108(suppl 2):323-34
9. Beck BD, Conolly RB, Dourson ML, et al. 1993. Improvements in quantitative noncancer risk assessment. Fundam Appl Toxicol 20:1-14
10. Bentley P, Calder I, Elcombe C, et al. 1993. Hepatic peroxisome proliferation in rodents and its significance for humans. Fd Chem Toxicol 31:857-907
11. Bernauer U, Birner G, Dekant W, et al. 1996. Biotransformation of trichloroethylene: Dose-dependent excretion of 2,2,2-trichlor-metabolites and mercapturic acids in rats and humans after inhalation. Arch Toxicol 70:338-46
12. Birner G, Vamvakas S, Dekant W, et al. 1993. Nephrotoxic and genotoxic N-acetyl-S-dichlorovinyl-L-cysteine is a urinary metabolite after occupational 1,1,2-trichloroethylene exposure in humans: implications for the risk of trichloroethylene exposure. Environ Health Perspect 99:281-4
13. Bogdanffy MS, Sarangapani R, Plowchalk DR, et al. 1999. A biologically based risk assessment for vinyl acetate-induced cancer and non-cancer inhalation toxicity. Toxicol Sci 51:19-35
14. Bogen KT and Gold LS. 1997. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points. Reg Toxicol Pharmacol 25:26-42
15. Bolt HM. 1987. Pharmacokinetic factors and their implication in the induction of mouse liver tumors by halogenated hydrocarbons. Arch Toxicol Suppl 10:190-203
16. Bolt H, Laib R, and FilserJ. 1982. Reactive metabolites and carcinogenicity of halogenated ethylenes. Biochem Pharmacol 31:1-4
17. Bondy SC. 1992. Ethanol toxicity and oxidative stress. Toxicol Lett 63:231-41
18. Brauch H, Weirich G, Hornauer MA, et al. 1999. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 91:854-61